Summary One third of 218 men and half of 1,576 women with low-energy distal radius fractures met the bone mineral density (BMD) criteria for osteoporosis treatment. A large proportion of patients with increased fracture risk did not have osteoporosis. Thus, all distal radius fracture patients ≥50 years should be referred to bone densitometry. Introduction Main objectives were to determine the prevalence of patients with a low-energy distal radius fracture in need of osteoporosis treatment according to existing guidelines using T-score ≤ −2.0 or ≤−2.5 standard deviation (SD) and calculate their fracture risk. Methods A total of 218 men and 1,576 women ≥50 years were included. BMD was assessed by dual energy X-ray absorptiometry (DXA) at femoral neck, total hip, and lumbar spine (L2-L4). The WHO fracture risk assessment tool (FRAX®) was applied to calculate the 10-year fracture risk.
Introduction
Osteoporosis is more common in Scandinavia than in any other part of the world, and the incidence of low-energy fractures, e.g., of the distal radius or hip, is among the highest worldwide [1] [2] [3] . A previous fracture, low bone density, and high age are the most important risk factors for low-energy fractures [4] [5] [6] . Persons with a low-energy distal radius fracture are also at increased risk of subsequent fractures both at the hip and spine [7] . Thus, a distal radius fracture may be the first presentation of a potentially devastating disease.
Osteoporosis treatment, e.g., with bisphosponates and denosumab, reduces the fracture risk significantly in postmenopausal women with osteoporosis [8] [9] [10] [11] . However, treatment has not been found to reduce fracture risk in patients with osteopenia. Guidelines based on costeffectiveness have been developed to allocate treatment to individuals at the highest risk of a new low-energy fracture [12, 13] . Some guidelines recommend considering treatment after a low-energy fracture in subjects aged 50 years and older with low bone mineral density (BMD) defined as a T-score ≤−2.0 standard deviation (SD) [14] [15] [16] or defined as a T-score ≤−2.5 SD (osteoporosis) [17, 18] . On the other hand, the National Institute of Health and Clinical Excellence (NICE) guideline suggests treatment for all women aged 75 years and older presenting with a low-energy fracture without the need of including bone measurements [19] .
The World Health Organization (WHO) fracture risk assessment tool (FRAX®) allows the 10-year risk of hip fracture and any major osteoporotic fracture (clinical spine, forearm, hip, or shoulder) to be calculated. The algorithm includes both demographic and clinical risk factors and can be used with or without taking the femoral neck BMD into consideration [20] . FRAX® has also been used to calculate cost effective treatment thresholds for medical intervention. In one study from USA, [21] FRAX® threshold for hip fracture was calculated to be 3%, whereas in one study from UK [22] FRAX® threshold for any major osteoporotic fracture was 7%.
Data on the prevalence of low BMD or osteoporosis in patients with distal radius fractures are scarce, and thus, the number of distal radius fracture patients in need of medical treatment according to treatment guidelines is unknown. In studies of small numbers of patients, BMD has been reported to be lower in distal radius fracture patients than in controls both in men [23] and women [13, 24, 25] . However, BMD has not been thoroughly investigated in large patient samples.
The aim of this study was to include both BMD measurements and FRAX® calculations in the study of a large group of patients with distal radius fractures aged 50 years and older. The main objectives were to determine the prevalence of patients in need of osteoporosis treatment defined as either a T-score ≤−2.0 SD according to, e.g., the Norwegian Medicines Agency's (NMA) or a T-score ≤−2.5 SD according to the WHO definition of osteoporosis, and to estimate the 10-year risk of hip fracture and any major osteoporotic fracture. A further aim was to investigate whether these patients had a lower age-and genderadjusted BMD (Z-score ≤−1.0 SD) than a healthy reference population.
Methods

Study design and patient recruitment
In 2003, in accordance with the osteoporosis guidelines of the NMA [15] , we established an automatic referral to bone densitometry in three Norwegian cities (Bergen, Kristiansand, and Skien) for all patients aged 50 years and older who suffered a low-energy distal radius fracture (Table 1 ). This routine assessment was based on the Fracture Liaison Service model set up in Glasgow [26] . Patients were consecutively recruited from the referral centers for orthopedic trauma: the Bergen Accident and Emergency Department and Haukeland University Hospital in Bergen, Sørlandet Hospital in Kristiansand, and Telemark Hospital in Skien. These patients were invited for osteoporosis assessment at the osteoporosis centers of their local hospital.
Clinical data were collected for fracture risk assessment, and BMD was measured. Patients with fractures due to obvious high-energy trauma were excluded. Low-energy fracture was defined as a result of minimal trauma, e.g., falling from standing height or less [27] . A distal radius fracture was defined as located within 3 cm of the radiocarpal joint [28] . Data were collected from March 2003 to December 2007. The study was approved by the National Data Inspectorate and the regional committees for medical research ethics.
Demographic and clinical data
As part of the clinical fracture risk assessment at the osteoporosis centers, a broad spectrum of demographic and clinical data was routinely collected as listed in Table 2 . The data were obtained both by self-report and interview by medical staff. At the osteoporosis centers, patients were given counseling and offered treatment in accordance with the NMA recommendations.
BMD measurements and reference population BMD was measured at the total hip, femoral neck, and lumbar spine (L2-L4) by dual energy X-ray absorptiometry (DXA) using Prodigy in Bergen and Kristiansand and EXPERT-XL in Skien (GE Lunar, Madison, WI). We chose to investigate the prevalence of T-score ≤−2.0 SD and T-score ≤−2.5 SD at femoral neck alone and at either total hip, femoral neck, or L2-L4 as both of these alternatives reflect common clinical practice [29] . The DXA machines were stable during the whole study period, and the in vitro long-term coefficient of variation (CV%) was 0.86% in Bergen, 0.62% in Kristiansand, and 0.92% in Skien. The in vivo short-term precision for total hip, femoral neck, and L2-L4 measurements were 0.77%, 1.47%, and 1.36% in Bergen, 0.89%, 1.56%, and 1.19% in Kristiansand, and 0.80%, 1.58%, and 1.50% in Skien. The mean time from the occurrence of the distal radius fracture until DXA measurements was 41 days in men and 49 days in women. The left hip was scanned unless there was a history of previous fracture or surgery; scans of the right hip were used in 103 (5.7%) patients. Due to bilateral fracture or surgery in 57 (3.6%) patients, only spine scans were used. In 11 (0.7%) patients, spine scans could not be analyzed due to degenerative changes.
The reference database used for T-score and Z-score calculations were provided by the DXA manufacturer as incorporated in the accompanying software. This European/ US reference population consists of 9,643 hip measurements, 11,460 femoral neck measurements, and 12,549 spine measurements of women aged 20 to 89 years [30] and a total of 3,163 hip measurements, 3,584 femoral neck measurements, and 2,880 spine measurements of men in the same age span. The database is compiled from several substudies of ambulatory subjects, and most exclude persons with previous fractures, chronic diseases, or medications known to influence bone metabolism. Scores were gender-specific, and reference population for calculation of T-score was young adults between 20 and 40 years old. Equations for the Z-score calculations have previously been published [31, 32] . Previous studies have shown that the European/US reference population database supplied by the manufacturer Lunar corresponds well with the Norwegian normal population across all adult age groups [33, 34] .
BMD was categorized according to the WHO definition of osteoporosis (T-score ≤−2.5 SD) and the NMA treatment guidelines (T-score ≤−2.0 SD). Normal BMD was defined as T-score ≥-1.0 SD. If T-score was ≤−2.0 SD at femoral neck, the patient was categorized as having low BMD and in need of treatment according to NMA. A patient was categorized to have osteoporosis if T-score was ≤−2.5 SD at femoral neck. We also investigated the proportion of patients with these Tscore levels at either total hip, femoral neck, or L2-L4. We divided the patients into 10-years age spans. Patients were also categorized according to a Z-score cut off <-1.0 SD.
The NICE guideline suggests treatment for all women aged 75 years and older presenting with a low-energy fracture without the need of BMD measurement [19] . According to this, we investigated the proportion of T-score ≤−2.5 SD at femoral neck in our women aged 75 years and older. We did the same in men aged 75 years and older.
Fracture risk assessed by FRAX®
The FRAX® model for predicting fracture risk is based on different patient cohorts from around the world including North America and Europe. It has been validated in independent cohorts with a similar geographic distribution [35] . We used the Swedish FRAX® model version 3.0 to estimate the 10-year risk of hip fracture and any major osteoporotic fracture (clinical spine, forearm, hip, or shoulder). The FRAX® model covers ages 40 to 90 years. For this reason, men (n=3) and women (n=25) older than 90 years were excluded from the FRAX® analyses. Six female patients from Asia were also excluded due to ethnicity other than Caucasian. The clinical risk factors included in the FRAX® model comprise information on race, age, sex, weight, height, femoral neck BMD (g/cm 2 ), a previous fracture, parental history of hip fracture, current smoking, use of oral glucocorticoids for more than three months, rheumatoid arthritis, other secondary causes of osteoporosis, and alcohol intake of three or more units per day [20] . Our questionnaire did not include the alcohol unit variable recommended in FRAX® as the participants only reported whether or not they considered themselves as alcohol abusers. The 10-year risk of hip fracture and any major osteoporotic fracture was calculated by FRAX® in two different ways: first, based on clinical risk factors only and thereafter, by including femoral neck BMD in the FRAX® algorithm. We combined the FRAX® results with respectively any-T-score, different T-scores, and across different age and fracture groups. Patients were divided into three groups according to fracture history after the age of 50 years; current distal radius fracture only, current and one previous fracture, and current and two or more previous fractures.
To evaluate treatment discordance for our population of distal radius fracture patients treated based on osteoporosis cut off alone versus those treated on the basis of a FRAX® threshold, we tested four different FRAX® intervention thresholds (>3%, >7%, >10%, and >15%), and compared with T-score ≤−2.5 SD at femoral neck.
Statistical analyses
Categorical variables were expressed as numbers and percentages, and continuous variables as means with variance expressed as SD or range. To compare BMD levels in our group of fracture patients with the reference population defined in the Lunar database, we evaluated the proportion of individuals with a Z-score ≤−1.0 SD [33] . Assuming a normal distribution, the risk is 0.68 of being within ±1 SD of the mean; thus, the expected proportion of Z-scores ≤−1.0 SD is 16% by default. The 95% confidence interval (CI) range for proportions of patients having a Z-score of ≤−1.0 SD was calculated using the equation for binomial distribution [36] . A two-tailed p value< 0.05 was considered statistically significant. All analyses were performed using SPSS software for Windows, version 15.0 (SPSS Inc., Chicago, IL).
Results
A total of 357 men and 2,349 women aged 50 years and older were identified as having suffered a distal radius fracture in the catchment areas during the recruitment period. Of these, 61.1% of the men (n=218) and 67.1% of the women (n= 1,576) were examined at their local osteoporosis clinics ( Table 1) . The mean (range) age was 65.3 years (50.3-91.5) for men and 67.8 years (50.1-99.8) for women. A previous low-energy fracture before the current distal radius fracture was found in 22.5% of the men and 31.8% of the women. Demographic data, clinical characteristics, and the BMD data of the participants are shown in Table 2 . No major differences in these data were found between the three osteoporosis centers (data not shown).
Prevalence of low BMD and indication for treatment
A total of 80 (37.7%) men and 779 (51.1%) women had a Tscore ≤−2.0 SD at femoral neck while 106 (48.6%) men and 1,000 (63.5%) women had a T-score ≤−2.0 SD at total hip, femoral neck, and/or L2-L4. T-scores ≤−2.5 SD at femoral neck were found in 42 (19.6%) men and 476 (31.2%) women. The corresponding figures at total hip, femoral neck, and/or L2-L4 were 71 (32.6%) in men and 715 (45.4%) in women. A normal femoral neck BMD (T-score ≥-1.0 SD) was found in 45 (22.1%) men and 289 (19.0%) women. Patients of both genders classified by age group and T-score level (−1.0 SD, −2.0 SD, −2.5 SD) for femoral neck are shown in Fig. 1 . In the youngest age groups the percentage of men with a T-score ≤−2.0 SD was the same as in women.
The proportion of men with a Z-score ≤−1.0 SD below the mean of controls for total hip, femoral neck, and L2-L4 was 38.2% (95% CI 31.7; 44.6), 40.2% (95% CI 33.5; Fig. 1 Prevalence of T-scores ≤−2.5 SD, >−2.5 SD, but ≤−2.0 SD, but >−1.0 SD and ≥−1.0 SD at femoral neck in male and female patients with low-energy distal radius fractures 46.9), and 49.1% (95% CI 42.4; 55.8), respectively. In women, the corresponding figures were 27.7% (95% CI 25.5; 29.9), 25.7% (95% CI 23.5; 27.9), and 31.5% (95% CI 29.2; 33.8), respectively. The highest proportions of patients with a Z-score ≤−1.0 SD were in the youngest age groups of both genders as shown in Fig. 2 .
Only 14 (32.6%) of the men and 225 (53.8%) of the women aged 75 years and older had indication for osteoporosis treatment (femoral neck T-score ≤−2.5 SD).
Fracture risk assessment
The 10-year risk of hip fracture calculated with BMD was 6.2% for men and 9.0% for women and of any major osteoporotic fracture 14.4% and 23.1%, respectively (Table 3 ). Men with a T-score ≤−2.5 SD had a 16.3% risk of hip fracture and a 25.1% risk of any major osteoporotic fracture. Equivalent figures for women were 18.2% and 34.7%. The fracture risk increased by age and by number of previous fractures (Table 3) . Compared with the rest of the male group, the oldest men with osteoporosis (T-score ≤−2.5 SD) had the highest risk of hip fracture (20.6%) and any major osteoporotic fracture (28.2%). The corresponding figures for women in the oldest age group were 21.9% and 39.7%. However, women with osteoporosis and a current and two or more previous fractures had the highest risk of hip fracture (24.2%) and any major osteoporotic fracture (40.2%). Equivalent figures in men were 20.6% and 28.2%. The 10-year hip fracture risk calculated without BMD was 5.8% for men and 13.2% for women and of any major osteoporotic fracture 13.8% and 27.7%, respectively ( Table 3) .
The prevalence of osteoporosis in patients with distal radius fracture as shown in Table 4 increased with increasing FRAX® score. However, a large proportion of patients even in those with a high FRAX® score did not have osteoporosis. Data are given as percentages. As FRAX® only accepts ages between 40 and 90 years, men (n=3) and women (n=25) over 90 years of age were excluded a FRAX® calculated without BMD b Because of the small number of patients in the oldest age groups, the groups were merged c Six female patients from Asia were excluded from the FRAX® analysis due to ethnicity other than Caucasian
Hip Fx hip fracture, Maj Fx any major osteoporotic fracture, SD standard deviation 
Discussion
This study highlights the significance of osteoporosis and its involvement in low-energy distal radius fractures in middleaged and elderly patients of both genders, and the FRAX® calculated increased risk of future fractures in these patients. As many as 38% of the men and 51% of the women aged 50 years and older with a distal radius fracture had an indication for treatment according to guidelines using a T-score threshold of ≤−2.0 SD at femoral neck, and about 20% of men and 31% of women using T-score ≤−2.5 SD. The prevalence of osteoporosis increased with increasing FRAX® score; but even in patients with a high FRAX® score, a large proportion of patients did not have osteoporosis.
To our knowledge, this is the largest study to explore the proportion of distal radius fracture patients in need of treatment according to BMD treatment guidelines and the first to estimate the 10-year risk of fractures using FRAX® in a population of patients with distal radius fractures. Despite the large number of patients, selection bias may have influenced our results as only 61% of male and 67% of female patients underwent densitometry. The oldest age groups, in particular, had a low participation rate. The participation rate was lower in Bergen than in the two other cities. Bergen is a larger city offering consultation for osteoporosis at several clinics, whereas the two smaller cites only have one orthopedic referral center each.
In the present study, DXA measurements and assessment of clinical risk factors were in average conducted within 2 months after the fracture. As retrospective data collection can be biased by recall problems, this may have influenced the results for some of the clinical variables, e.g., loss of height, menopause, and previous fractures.
Although no specific FRAX® model has been developed for the Norwegian population, the incidences of low-energy fractures have been shown to be comparable in the Scandinavian countries and are among the highest in the world [1] [2] [3] . Thus, the Swedish FRAX® model is probably also reliable for the Norwegian population. The optimal estimate of alcohol consumption as a risk factor according to FRAX® is three or more units per day. In our study, participants simply reported whether or not they considered themselves to be alcohol abusers. This may have lead to misclassifications, and we may have underestimated the 10-year risk of fractures in some patients especially among the younger men with low BMD.
In previous studies, lower BMD in patients with a distal radius fracture compared with controls has been reported in both men [23] and women [14, 24, 25, 37] . However, in two studies where heel BMD was used, no differences were found between patients with a distal radius fracture and controls [38, 39] . The impact of low BMD in younger and older age groups is inconsistent in previous studies. In one small study, odds ratio for having low BMD were significantly greater in women younger than 65 years than in those aged 65 years and older presenting with a distal radius fracture [24] while, in another study, reduced BMD was more frequently seen in elderly distal radius fracture patients aged 65 years and older than in those younger than 65 years [40] . Contradictive results like this may be attributed to qualitative and quantitative differences between the examined cohorts as well as methodological discrepancies related to, e.g., patient recruitment and study design. The number of participants in all these studies are relatively small compared with our cohort of distal radius fracture patients.
The total prevalence of low BMD (T-score ≤−2.0 SD) and osteoporosis (T-score ≤−2.5 SD) in our study is similar to findings in two previous studies on women [25, 26] . Löfman et al. [25] found T-scores <−2.0 SD in 53% and <−2.5 SD (osteoporosis) in 37% at total hip or spine in 171 Swedish women (mean age, 67 years) with distal radius fractures while McLellan et al. [26] diagnosed osteoporosis at the same measurement sites in 41% of the 420 Glasgow women aged 50 years and older with similar fractures.
There are limited BMD data on distal radius fractures in men [23, 41] . The prevalence of osteoporosis in men was higher in our study (33%) compared with the Fracture Liaison Service study in Glasgow. A total of 221 men with a distal radius fracture (mean age, 65 years) were reported to have 23% prevalence of osteoporosis at total hip, femoral neck, or spine [41] . In a small British study of 67 men (mean age, 61 years), as many as 42% were diagnosed with osteoporosis at the same measurements sites [23] .
A previous low-energy fracture in middle-aged and elderly patients is a predictor for osteoporosis and subsequent fractures [4] [5] [6] [7] , and several guidelines recommend bone densitometry for these patients [14-18, 42, 43] . The NICE guideline recommends treatment for all female patients aged 75 years and older with a low-energy fracture without the need of BMD measurement [19] . If we had followed the NICE guidelines, 67% of the men and 46% of the women would receive treatment without having osteoporosis. The evidence that fracture patients without osteoporosis will benefit from treatment is weak. Thus, bone densitometry should be performed before starting osteoporosis treatment to avoid over treatment.
Compared with hip fractures, costs associated with distal radius fractures are relatively low and the long-term impact on future quality of life is limited [44] . Distal radius fractures have been shown to occur at an average of 15 years earlier in life than hip fractures [45] and can predict future hip and vertebral fractures [7] . In the current study, the highest proportion of patients with low age-and gender-adjusted BMD (Z-score ≤−1.0 SD) was found among the youngest groups of middle-aged men and women ( Fig. 2 and Table 3) . A good fracture preventive strategy would be to designate distal radius fracture patients as a target group to detect and treat osteoporosis at an early stage. This could reduce the future risk of the devastating consequences of osteoporosis [7, 46] . Pharmacological antiresorptive therapy has been shown to reduce the total fracture risk in postmenopausal women [8] [9] [10] and vertebral fractures in middle-aged and elderly men with primary osteoporosis [47] . The clinical implication of identifying these patients is further emphasized as antiresorptive treatment has been shown to be cost-effective in women with previous fracture and low BMD [22] .
Analysis from the USA have shown cost-effectiveness in treating patients aged 50 years and older if the 10-year risk of a hip fracture (calculated without BMD) reached approximately 3% [21] , and analyses from the UK have shown that treatment is cost-effective at a major osteoporotic fracture probability of 7% (calculated with BMD) [22] . In our population of distal radius fracture patients, only 25% of the men and 35% of the women did have osteoporosis due to the US FRAX® intervention threshold and only 20% of the men and 31% of the women due to the UK FRAX® intervention threshold. The prevalence of osteoporosis increased with increasing FRAX® score, but even when the FRAX® score was above 15%, a large proportion of patients did not have osteoporosis as shown in Table 4 . The percentage of cost-effectiveness will differ from country to country depending on, e.g., the willingness of society or patient to pay, gross domestic product, and fracture rates [48] . However, our results show that all distal radius fracture patients ≥50 years should be referred to bone densitometry before starting osteoporosis treatment. Today, the most disappointing fact is the low follow-up rate of these patients at risk of subsequent fractures. Generally, less than 10% are referred to further consultation or treatment for osteoporosis [49, 50] .
In conclusion, our data emphasize the same need of an increased awareness of osteoporosis in both middle-aged men and women as well as in elderly patients with lowenergy distal radius fractures. Every second to every third fracture patient met the present BMD criteria for osteoporosis treatment. A high prevalence of patients with a high FRAX® score did not have osteoporosis. Our data further highlights that treatment decisions should not be based on fracture risk assessment for future fracture risk alone but also include assessment of osteoporosis. Thus, all men and women aged 50 years and older with a distal radius fracture should be referred to osteoporosis assessment and, if indicated, treated.
